Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?

ABSTRACT:

SUBMITTER: Maguire C 

PROVIDER: S-EPMC7309524 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature